日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Health workforce implications of integrating NCD prevention, screening and treatment into hospital-based MNCH services: perspectives from Kyrgyzstan, Tajikistan and Viet Nam

将非传染性疾病预防、筛查和治疗纳入医院妇幼保健服务对卫生人力资源的影响:来自吉尔吉斯斯坦、塔吉克斯坦和越南的视角

Collins, Téa E; Karapici, Amanda; Maliqi, Blerta; Berlina, Daria; Akselrod, Svetlana; Yaqub, Nuhu; Were, Wilson M; Banerjee, Anshu; Tainijoki, Julia; Altymysheva, Aliina; Pham, Thi Quynh Nga; Shoismatuloeva, Mekhri

Animal-Free Derived Collagen-Like Protein Based Electrospun Nanofibers for Biomedical Applications: Cell Interactions Studies

用于生物医学应用的无动物源胶原蛋白样蛋白基静电纺丝纳米纤维:细胞相互作用研究

Krauss, Christoph; Montero Mirabet, Maria; Thaqi, Blerta Sonja; Weber, Sven; Mäder, Karsten

MEWDS-like Presentation Unmasking Sequential Bilateral Multifocal Choroiditis: Insights from Longitudinal Multimodal Imaging

MEWDS样表现揭示双侧多灶性脉络膜炎的序贯性表现:来自纵向多模态成像的启示

Lang, Blerta; Rickmann, Annekatrin; Boden, Karl Thomas; Behnke, Stefanie; Szurman, Peter

Germline-Somatic Liaison Dictates Cancer Subtypes via de novo Steroid Biosynthesis.

生殖细胞-体细胞联系通过从头合成类固醇决定癌症亚型。

Gasperini Paola, Alaimo Alessandro, Stringa Blerta, Chung Yoon-Mi, Ciani Yari, Lorenzin Francesca, Fracassi Giulia, Zekri Yanis, Orlando Francesco, Quaini Orsetta, Gregoricchio Sebastian, Petris Gianluca, Casini Antonio, Barbieri Christopher E, Zwart Wilbert, Cereseto Anna, Sharifi Nima, Lunardi Andrea, Demichelis Francesca

NAT10 and N(4)-acetylcytidine restrain R-loop levels and related inflammatory responses.

NAT10 和 N(4)-乙酰胞苷抑制 R 环水平和相关的炎症反应

Debnath Turja K, Abell Nathan S, Li Yi-Ru, Devanathan Sravan K, Navedo Enrique, Xhemalçe Blerta

MePCE promotes homologous recombination through coordinating R-loop resolution at DNA double-stranded breaks.

MePCE 通过协调 DNA 双链断裂处的 R 环解析来促进同源重组

Devanathan Sravan K, Li Yi-Ru, Shelton Samantha B, Nguyen Joshuah, Tseng Wei-Che, Shah Nakul M, Mercado Marvin, Miller Kyle M, Xhemalçe Blerta

Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience

早期干预及单克隆抗体联合抗病毒药物治疗SARS-CoV-2感染的肿瘤血液病患者的疗效:一项回顾性研究

Di Bari, Silvia; Izzo, Francesco; Bresciani, Livia; Mancarella, Giulia; Garattini, Silvia; Gasperin, Andrea; Di Trento, Daniela; Grimaldi, Alessandra; Parente, Alberico; Marocco, Raffaella; Carraro, Anna; Kertusha, Blerta; Tieghi, Tiziana; Del Borgo, Cosmo; Vita, Serena; Guardiani, Mariasilvia; Pasquazzi, Caterina; Spagnoli, Alessandra; Alunni Fegatelli, Danilo; Lichtner, Miriam

A Novel Two-Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing in Multiple Myeloma Patients

一种用于描述多发性骨髓瘤患者接受Elranatamab给药后细胞因子释放综合征发生率和时间进程的新型两部分混合模型

Irby, Donald; Hibma, Jennifer; Elmeliegy, Mohamed; Wang, Diane; Vandendries, Erik; Poels, Kamrine; Shtylla, Blerta; Williams, Jason H

Measuring the impact of the network for improving quality of care for maternal, newborn, and child health: methods, findings, and lessons learned

评估该网络对改善孕产妇、新生儿和儿童健康护理质量的影响:方法、发现和经验教训

Muzigaba, Moïse; Diaz, Theresa; Rao, Sowmya R; Mbewe, Malangizo; Dohlsten, Martin; Lopez, Gerard; Maliqi, Blerta

Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myeloma

利用定量系统药理学模型优化复发或难治性多发性骨髓瘤患者的elranatamab治疗方案

Poels, Kamrine E; Elmeliegy, Mohamed; Hibma, Jennifer; Wang, Diane; Musante, Cynthia J; Shtylla, Blerta